… of Parkinson’s disease (PD) is on the rise. In recent years, inflammatory processes have
emerged … and iPSC-derived models, newly emerging technologies, and the resulting potential of …

Parkinson’s disease (PD) is the second most common neurodegenerative disease worldwide,
and its treatment remains a big challenge. The pathogenesis of PD may be related to …

… already emerging from clinical trials in which patients with PD have been exposed to agents
licensed for the treatment of T2DM, during which the severity of their Parkinson's disease …

… microbiome suggests alterations linked to intestinal inflammation | npj Parkinson's Disease
… The gut microbiota is emerging as an important modulator of neurodegenerative diseases, …

… and Parkinson's disease. … disease, Parkinson's disease and Huntington's disease. Besides,
UPR mt is also involved in the occurrence and development of cancers and heart diseases. …

… The most common surgical target for the treatment of Parkinson's disease is the subthalamic
nucleus, which contains ~250,000 neurons, depicted in blue, and is much denser in reality …

… in the brain stem are characteristic features of Parkinson's disease (PD). Nanotube arrays
… in degenerative diseases such as Alzheimer's disease and Parkinson's disease, which …

… However, gold nanoparticles are emerging with Phase II clinical trials underway for multiple
sclerosis, amyotrophic lateral sclerosis, and Parkinson’s disease, which will be discussed …

… emerged, the study on the role of green tea and its constituents in counteracting a diverse
range of disease … This review mainly focusses on Parkinson’s disease (PD) and the molecular …

… The single-drug–single-target approach has long dominated the pharmaceutical industry
with many successful drugs emerging from such a strategy. However, many diseases remain …